{
    "ticker": "BIOR",
    "name": "Bionano Genomics, Inc.",
    "description": "Bionano Genomics, Inc. is a life sciences company focused on advancing the field of genomics through its innovative optical genome mapping technology. Founded in 2003 and headquartered in San Diego, California, Bionano aims to revolutionize genome analysis by providing a deeper understanding of genetic variations that may contribute to diseases such as cancer. The company\u2019s flagship product, the Saphyr system, enables researchers and clinicians to perform high-resolution mapping of genomes, thereby facilitating the identification of structural variations that are often missed by traditional sequencing methods. Bionano\u2019s technology is especially valuable in oncology, inherited diseases, and reproductive health, supporting researchers in their quest for personalized medicine solutions. With a commitment to scientific innovation, Bionano Genomics collaborates with leading academic institutions and healthcare providers to enhance genomic research and improve clinical outcomes. The company is dedicated to making genome analysis more accessible and efficient, ultimately empowering scientists and clinicians in their efforts to understand and treat genetic disorders.",
    "industry": [
        "Biotechnology",
        "Genomics"
    ],
    "headquarters": "San Diego, California, USA",
    "founded": "2003",
    "website": "https://www.bionanogenomics.com",
    "ceo": "Erik Holmlin",
    "social_media": {
        "twitter": "https://twitter.com/BionanoGenomics",
        "linkedin": "https://www.linkedin.com/company/bionano-genomics/"
    },
    "investor_relations": "https://investors.bionanogenomics.com",
    "key_executives": [
        {
            "name": "Erik Holmlin",
            "position": "CEO"
        },
        {
            "name": "Mark R. Schena",
            "position": "Chairman"
        }
    ],
    "product_categories": [
        {
            "category": "Genomic Solutions",
            "products": [
                "Saphyr System",
                "OGM Kits"
            ]
        }
    ],
    "seo": {
        "meta_title": "Bionano Genomics, Inc. | Optical Genome Mapping Innovations",
        "meta_description": "Explore Bionano Genomics, Inc., a leader in genomic analysis with its cutting-edge optical genome mapping technology. Learn about our mission and products.",
        "keywords": [
            "Bionano Genomics",
            "Optical Genome Mapping",
            "Genomics",
            "Saphyr System",
            "Cancer Research",
            "Genetic Disorders"
        ]
    },
    "faq": [
        {
            "question": "What is Bionano Genomics known for?",
            "answer": "Bionano Genomics is known for its optical genome mapping technology that enhances the analysis of genomes."
        },
        {
            "question": "Who is the CEO of Bionano Genomics?",
            "answer": "Erik Holmlin is the CEO of Bionano Genomics, Inc."
        },
        {
            "question": "Where is Bionano Genomics headquartered?",
            "answer": "Bionano Genomics is headquartered in San Diego, California, USA."
        },
        {
            "question": "What are Bionano Genomics' main products?",
            "answer": "Bionano Genomics' main products include the Saphyr system and OGM kits."
        },
        {
            "question": "When was Bionano Genomics founded?",
            "answer": "Bionano Genomics was founded in 2003."
        }
    ],
    "competitors": [
        "PACB",
        "ILMN",
        "GRMN"
    ],
    "related_stocks": [
        "NVTA",
        "CDNA",
        "EDIT",
        "CRSP"
    ]
}